Rtw Investments, LP Biocryst Pharmaceuticals Inc Transaction History

Rtw Investments, LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2018 May 14, 2018	SELL	$4.35 - $5.82 $14.7 Million - $19.6 Million	-3,372,674 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$4.16 - $5.33 $199,551 - $255,674	47,969 Added 1.44%	3,372,674 $16.6 Million
Q3 2017 Nov 14, 2017	BUY	$4.1 - $5.97 $13.6 Million - $19.8 Million	3,324,705	3,324,705 $17.4 Million

279

172M

625K

739K

Ticker BCRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,944,992
Market Cap $1.41B
Description
BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...

Get notified when there are updates to the investment portfolio of Rtw Investments, LP, based on Form 13F filings with the SEC.

Stay updated on Rtw Investments, LP with notifications on news.